| scholarly article | Q13442814 |
| P50 | author | Kenneth L. Byron | Q41538983 |
| Bharath K Mani | Q57338159 | ||
| P2093 | author name string | Lalit Kumar | |
| Lioubov I Brueggemann | |||
| Masey Ross | |||
| James O'Dowd | |||
| P2860 | cites work | Calcium antagonists for aneurysmal subarachnoid haemorrhage | Q24244167 |
| Activation of the JAK-STAT signaling pathway in the rat basilar artery after subarachnoid hemorrhage | Q28569925 | ||
| Serotonin inhibits voltage-gated K+ currents in pulmonary artery smooth muscle cells: role of 5-HT2A receptors, caveolin-1, and KV1.5 channel internalization | Q28576272 | ||
| New insights into the causes and therapy of cerebral vasospasm following subarachnoid hemorrhage | Q30445777 | ||
| Systemic administration of the potassium channel activator cromakalim attenuates cerebral vasospasm after experimental subarachnoid hemorrhage | Q30471731 | ||
| Role of potassium channels in regulation of brain arteriolar tone: comparison of cerebrum versus brain stem | Q30977501 | ||
| Overexpression of cyclooxygenase-2 in rabbit basilar artery endothelial cells after subarachnoid hemorrhage | Q30984465 | ||
| Neurological and neurobehavioral assessment of experimental subarachnoid hemorrhage | Q33496591 | ||
| Neuronal KCNQ potassium channels: physiology and role in disease. | Q34185467 | ||
| Protein kinase C and cerebral vasospasm | Q34327417 | ||
| Retigabine: chemical synthesis to clinical application. | Q34415600 | ||
| Fundamental increase in pressure-dependent constriction of brain parenchymal arterioles from subarachnoid hemorrhage model rats due to membrane depolarization. | Q34720266 | ||
| Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association | Q34928426 | ||
| Oxidative modification of M-type K(+) channels as a mechanism of cytoprotective neuronal silencing | Q35102221 | ||
| Functional ion channels in human pulmonary artery smooth muscle cells: Voltage-dependent cation channels | Q35214857 | ||
| Activation of vascular KCNQ (Kv7) potassium channels reverses spasmogen-induced constrictor responses in rat basilar artery. | Q35216454 | ||
| Possible cellular mechanism for cerebral vasospasm after experimental subarachnoid hemorrhage in the dog. | Q35579181 | ||
| Kv7 potassium channels in airway smooth muscle cells: signal transduction intermediates and pharmacological targets for bronchodilator therapy. | Q35950205 | ||
| Signal transduction pathways and gating mechanisms of native TRP-like cation channels in vascular myocytes | Q36272878 | ||
| Bilirubin oxidation products (BOXes) and their role in cerebral vasospasm after subarachnoid hemorrhage | Q36391810 | ||
| Ion channels and calcium signaling in cerebral arteries following subarachnoid hemorrhage | Q36681454 | ||
| Mechanisms of vascular dysfunction after subarachnoid hemorrhage | Q36716182 | ||
| Vascular KCNQ potassium channels as novel targets for the control of mesenteric artery constriction by vasopressin, based on studies in single cells, pressurized arteries, and in vivo measurements of mesenteric vascular resistance. | Q37001792 | ||
| Molecular mechanisms of cerebral vasospasm following aneurysmal SAH. | Q37049581 | ||
| A review of hemoglobin and the pathogenesis of cerebral vasospasm | Q37230741 | ||
| Pathogenesis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage: putative mechanisms and novel approaches. | Q37246038 | ||
| Differential effects of selective cyclooxygenase-2 inhibitors on vascular smooth muscle ion channels may account for differences in cardiovascular risk profiles. | Q37415814 | ||
| Voltage-gated potassium channels as therapeutic targets | Q37464784 | ||
| The mechanism of action of retigabine (ezogabine), a first-in-class K+ channel opener for the treatment of epilepsy | Q37973378 | ||
| Bilirubin oxidation end products directly alter K+ channels important in the regulation of vascular tone | Q39710047 | ||
| Cerebral vasospasm following aneurysmal subarachnoid hemorrhage | Q39826081 | ||
| Physiological roles and properties of potassium channels in arterial smooth muscle | Q40515388 | ||
| Regulation of 4-aminopyridine-sensitive, delayed rectifier K+ channels in vascular smooth muscle by phosphorylation | Q41263679 | ||
| Molecular expression and pharmacological identification of a role for K(v)7 channels in murine vascular reactivity | Q41590646 | ||
| Regulation of membrane potential and diameter by voltage-dependent K+ channels in rabbit myogenic cerebral arteries | Q41678563 | ||
| KCNQ modulators reveal a key role for KCNQ potassium channels in regulating the tone of rat pulmonary artery smooth muscle | Q42110971 | ||
| Hypotensive effect of nimodipine during treatment for aneurysmal subarachnoid haemorrhage | Q42554818 | ||
| Participation of KCNQ (Kv7) potassium channels in myogenic control of cerebral arterial diameter | Q42972474 | ||
| Protective effects of Celecoxib on lung injury and red blood cells modification induced by carrageenan in the rat. | Q43981327 | ||
| The use of mild hypothermia for patients with severe vasospasm: a preliminary report | Q48364909 | ||
| Mild hypothermia (33 degrees C) reduces intracranial hypertension and improves functional outcome after subarachnoid hemorrhage in rats | Q48510614 | ||
| Retigabine and flupirtine exert neuroprotective actions in organotypic hippocampal cultures. | Q48541850 | ||
| The neuroprotective effects of cyclooxygenase-2 inhibition in a mouse model of aneurysmal subarachnoid hemorrhage | Q49094850 | ||
| Oxyhemoglobin-induced suppression of voltage-dependent K+ channels in cerebral arteries by enhanced tyrosine kinase activity. | Q53591254 | ||
| Effect of protein kinase C inhibitors on endothelin- and vasopressin-induced constriction of the rat basilar artery | Q67986289 | ||
| Role of protein kinase C in constrictor responses of the rat basilar artery in vivo | Q68013288 | ||
| Effects of cromakalim, pinacidil and nicorandil on cardiac refractoriness and arterial pressure in open-chest dogs | Q68421695 | ||
| Relaxation of subarachnoid hemorrhage-induced spasm of rabbit basilar artery by the K+ channel activator cromakalim | Q70924720 | ||
| Functional effects of 4-aminopyridine (4-AP) on pulmonary and systemic vessels from normoxic control and hypoxic pulmonary hypertensive rats | Q73137107 | ||
| Flupirtine and retigabine prevent L-glutamate toxicity in rat pheochromocytoma PC 12 cells | Q74317079 | ||
| Comparison of three rat models of cerebral vasospasm | Q78503786 | ||
| Voltage-gated K+ channel dysfunction in myocytes from a dog model of subarachnoid hemorrhage | Q81561970 | ||
| Neuroprotective effects of Kv7 channel agonist, retigabine, for cisplatin-induced peripheral neuropathy | Q84982252 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 51-62 | |
| P577 | publication date | 2013-01-01 | |
| P1433 | published in | Journal of Cardiovascular Pharmacology | Q2125808 |
| P1476 | title | Vascular KCNQ (Kv7) potassium channels as common signaling intermediates and therapeutic targets in cerebral vasospasm | |
| P478 | volume | 61 |
| Q47443094 | 4-Aminopyridine: a pan voltage-gated potassium channel inhibitor that enhances Kv 7.4 currents and inhibits noradrenaline-mediated contraction of rat mesenteric small arteries |
| Q88446564 | Angiotensin II Promotes KV7.4 Channels Degradation Through Reduced Interaction With HSP90 (Heat Shock Protein 90) |
| Q35044810 | Augmentation of M-type (KCNQ) potassium channels as a novel strategy to reduce stroke-induced brain injury |
| Q47285240 | Cerebral artery myogenic reactivity: The next frontier in developing effective interventions for subarachnoid hemorrhage |
| Q37511713 | Differential protein kinase C-dependent modulation of Kv7.4 and Kv7.5 subunits of vascular Kv7 channels. |
| Q35098568 | Functional and molecular evidence for Kv7 channel subtypes in human detrusor from patients with and without bladder outflow obstruction |
| Q35538269 | Heterogeneity in Kv7 channel function in the cerebral and coronary circulation |
| Q60045702 | Impaired Kv7 channel function in cerebral arteries of a tauopathy mouse model (rTg4510) |
| Q41958830 | Inflammation, vasospasm, and brain injury after subarachnoid hemorrhage |
| Q46820919 | KV7 Channel Pharmacological Activation by the Novel Activator ML213: Role for Heteromeric KV7.4/KV7.5 Channels in Guinea Pig Detrusor Smooth Muscle Function. |
| Q47701761 | Kv7 potassium channels as signal transduction intermediates in the control of microvascular tone |
| Q36618785 | Kv7.5 Potassium Channel Subunits Are the Primary Targets for PKA-Dependent Enhancement of Vascular Smooth Muscle Kv7 Currents. |
| Q35000941 | Molecular expression and pharmacological evidence for a functional role of kv7 channel subtypes in Guinea pig urinary bladder smooth muscle |
| Q47656632 | Perivascular adipose tissue and the dynamic regulation of Kv 7 and Kir channels: Implications for resistant hypertension |
| Q97420402 | Pharmacological Manipulation of K v 7 Channels as a New Therapeutic Tool for Multiple Brain Disorders |
| Q34801200 | Role of Kv7 channels in responses of the pulmonary circulation to hypoxia |
| Q37535568 | Serum starvation-induced voltage-gated potassium channel Kv7.5 expression and its regulation by Sp1 in canine osteosarcoma cells |
| Q90399746 | The KV 7 channel activator retigabine suppresses mouse urinary bladder afferent nerve activity without affecting detrusor smooth muscle K+ channel currents |
| Q35962040 | The Novel KV7.2/KV7.3 Channel Opener ICA-069673 Reveals Subtype-Specific Functional Roles in Guinea Pig Detrusor Smooth Muscle Excitability and Contractility |
| Q60918223 | Understanding phosphoinositides: rare, dynamic, and essential membrane phospholipids |
| Q44400605 | XE991 and Linopirdine Are State-Dependent Inhibitors for Kv7/KCNQ Channels that Favor Activated Single Subunits |
Search more.